More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs.

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

MEDLEMSNYHET - The medical technology group Smith+Nephew uses an AI-supported light microscope ZEISS Axio Imager to inspect ...

A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).

MEDLEMSNYHET - SignalChem Biotech (part of Sino Biological) offers integrated solutions to support kinase drug discovery, spanning target discovery to compound screening, profiling, and optimization.

Sjukdomars sällsynthet får nu ännu större betydelse när TLV ändrar sina arbetssätt. Förhoppningen är att tillgången till ...

Rådet består sedan innan av ordförande Sven-Eric Söder och ledamöterna Yasmine Bladelius (S), Åsa Gyberg-Karlsson (V), Per ...

Oskar Hansson, a professor of neurology at Lund University, will hold the title of Vice President for Neurodegenerative Disease Early Phase Clinical and Imaging Development at the American ...

Ultimovacs is developing the cancer vaccine UV1, which aims to enhance and improve the effect of immunotherapy in various forms of cancer. Zelluna is developing immunotherapies against solid tumors.

Approximately 60-70% of infectious diseases are viral, including COVID-19, influenza, MPXV, HIV, and Ebola. These viruses continue to affect human health and socio-economic development. Therefore, it ...

Enligt ett pressmeddelande avgår Hans Wigzell på egen begäran, och styrelsen inleder omedelbart arbetet för att hitta en ny ordförande. Någon orsak anges inte, men beskedet kommer bara en dryg vecka ...

American Merck & Co, known in Europe as MSD, has discontinued the development of vibostolimab and favezelimab, two experimental cancer drugs, after their failure in several trials, according to a ...